Obstruction of a dysmorphic ureter following dextranomer/hyaluronic acid copolymer.
Snodgrass
Warren T
WT
Department of Urology, University of Texas Southwestern Medical School and Children's Medical Center, Dallas, 75235-9142, USA. wsnodg@childmed.dallas.tx.us
D002675:Child, Preschool; D003911:Dextrans / Q000008:administration & dosage / Q000009:adverse effects*; D005260:Female; D006801:Humans; D006820:Hyaluronic Acid / Q000008:administration & dosage / Q000009:adverse effects*; D007267:Injections; D011108:Polymers / Q000008:administration & dosage / Q000009:adverse effects*; D014513:Ureter / Q000002:abnormalities*; D014517:Ureteral Obstruction / Q000209:etiology*; D014718:Vesico-Ureteral Reflux / Q000628:therapy
D003911:Dextrans; D011108:Polymers; C013471:dextranomer; D006820:Hyaluronic Acid